<VariationArchive VariationID="2035265" VariationName="NM_003002.4(SDHD):c.136_143del (p.Val46fs)" VariationType="Deletion" Accession="VCV002035265" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-23" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2100923" VariationID="2035265">
      <GeneList>
        <Gene Symbol="SDHD" FullName="succinate dehydrogenase complex subunit D" GeneID="6392" HGNC_ID="HGNC:10683" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>11q23.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112086873" stop="112095794" display_start="112086873" display_stop="112095794" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111957570" stop="111966517" display_start="111957570" display_stop="111966517" Strand="+" />
          </Location>
          <OMIM>602690</OMIM>
          <Haploinsufficiency last_evaluated="2021-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHD">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-08-11" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SDHD">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_003002.4(SDHD):c.136_143del (p.Val46fs)</Name>
      <CanonicalSPDI>NC_000011.10:112087938:AGTGCAGCA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>11q23.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="11" Accession="NC_000011.10" start="112087939" stop="112087946" display_start="112087939" display_stop="112087946" variantLength="8" positionVCF="112087938" referenceAlleleVCF="GAGTGCAGC" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="11" Accession="NC_000011.9" start="111958663" stop="111958670" display_start="111958663" display_stop="111958670" variantLength="8" positionVCF="111958662" referenceAlleleVCF="GAGTGCAGC" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>V46fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.10" sequenceAccession="NC_000011" sequenceVersion="10" change="g.112087940_112087947del" Assembly="GRCh38">
            <Expression>NC_000011.10:g.112087940_112087947del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000011.9" sequenceAccession="NC_000011" sequenceVersion="9" change="g.111958664_111958671del" Assembly="GRCh37">
            <Expression>NC_000011.9:g.111958664_111958671del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012337.3" sequenceAccession="NG_012337" sequenceVersion="3" change="g.6094_6101del">
            <Expression>NG_012337.3:g.6094_6101del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_033145.1" sequenceAccession="NG_033145" sequenceVersion="1" change="g.3853_3860del">
            <Expression>NG_033145.1:g.3853_3860del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_123945.1" sequenceAccession="NG_123945" sequenceVersion="1" change="g.204_211del">
            <Expression>NG_123945.1:g.204_211del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276503.2" sequenceAccession="NM_001276503" sequenceVersion="2" change="c.136_143del">
            <Expression>NM_001276503.2:c.136_143del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263432.1" sequenceAccession="NP_001263432" sequenceVersion="1" change="p.Val46fs">
            <Expression>NP_001263432.1:p.Val46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276506.2" sequenceAccession="NM_001276506" sequenceVersion="2" change="c.136_143del">
            <Expression>NM_001276506.2:c.136_143del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001263435.1" sequenceAccession="NP_001263435" sequenceVersion="1" change="p.Val46fs">
            <Expression>NP_001263435.1:p.Val46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003002.4" sequenceAccession="NM_003002" sequenceVersion="4" change="c.136_143del" MANESelect="true">
            <Expression>NM_003002.4:c.136_143del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_002993.1" sequenceAccession="NP_002993" sequenceVersion="1" change="p.Val46fs">
            <Expression>NP_002993.1:p.Val46fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_077060.2" sequenceAccession="NR_077060" sequenceVersion="2" change="n.171_178del">
            <Expression>NR_077060.2:n.171_178del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001276504.2" sequenceAccession="NM_001276504" sequenceVersion="2" change="c.53-927_53-920del">
            <Expression>NM_001276504.2:c.53-927_53-920del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001627" Type="intron variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_9" sequenceAccession="LRG_9">
            <Expression>LRG_9:g.6094_6101del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_9t1" sequenceAccession="LRG_9t1">
            <Expression>LRG_9t1:c.136_143del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_9p1" sequenceAccession="LRG_9p1" change="p.Val46fs">
            <Expression>LRG_9p1:p.Val46fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003002.4(SDHD):c.136_143del (p.Val46fs) AND multiple conditions" Accession="RCV002889946" Version="2">
        <ClassifiedConditionList TraitSetID="73586">
          <ClassifiedCondition DB="MedGen" ID="C1847319">Carney-Stratakis syndrome</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="CN166604">Cowden syndrome 3</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C1868633">Paragangliomas with sensorineural hearing loss</ClassifiedCondition>
          <ClassifiedCondition DB="MedGen" ID="C0031511">Pheochromocytoma</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-12" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-12" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-02-08" MostRecentSubmission="2024-02-28">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19454582</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19802898</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="73586" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3796" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pheochromocytoma</ElementValue>
                <XRef ID="Pheochromocytoma/5718" DB="Genetic Alliance" />
                <XRef ID="HP:0002666" DB="Human Phenotype Ontology" />
                <XRef ID="MONDO:0008233" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chromaffinoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chromaffin paraganglioma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chromaffin tumor</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Medullary paraganglioma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Chromaffin cell tumor</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Hereditary paraganglioma-pheochromocytoma (PGL/PCC) syndromes are characterized by paragangliomas (tumors that arise from neuroendocrine tissues distributed along the paravertebral axis from the base of the skull to the pelvis) and pheochromocytomas (paragangliomas that are confined to the adrenal medulla). Sympathetic paragangliomas cause catecholamine excess; parasympathetic paragangliomas are most often nonsecretory. Extra-adrenal parasympathetic paragangliomas are located predominantly in the skull base and neck (referred to as head and neck PGL [HNPGL]) and sometimes in the upper mediastinum; approximately 95% of such tumors are nonsecretory. In contrast, sympathetic extra-adrenal paragangliomas are generally confined to the lower mediastinum, abdomen, and pelvis, and are typically secretory. Pheochromocytomas, which arise from the adrenal medulla, typically lead to catecholamine excess. Symptoms of PGL/PCC result from either mass effects or catecholamine hypersecretion (e.g., sustained or paroxysmal elevations in blood pressure, headache, episodic profuse sweating, forceful palpitations, pallor, and apprehension or anxiety). The risk for developing metastatic disease is greater for extra-adrenal sympathetic paragangliomas than for pheochromocytomas.</Attribute>
                <XRef ID="NBK1548" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">TMEM127-Related Susceptibility to Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">RET-Related Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">KIF1B-Related Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MAX-Related Susceptibility to Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">VHL-Related Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="15105" />
                <XRef ID="15105" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Hereditary cancer syndrome</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SDHB-Related Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">SDHD-Related Pheochromocytoma</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">Neoplasm</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">MAX-Related Hereditary Paraganglioma-Pheochromocytoma Syndrome</Attribute>
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301715</ID>
                <ID Source="BookShelf">NBK1548</ID>
              </Citation>
              <Citation Type="general" Abbrev="ES, 2014">
                <ID Source="PubMed">24893135</ID>
              </Citation>
              <Citation Type="general" Abbrev="ASCO, 2014">
                <ID Source="PubMed">24493721</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2010">
                <ID Source="PubMed">20664475</ID>
                <ID Source="pmc">3419007</ID>
              </Citation>
              <Citation Type="general" Abbrev="KCRNC, 2013">
                <ID Source="PubMed">24319509</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <Citation Type="general" Abbrev="NANETS, 2021">
                <ID Source="PubMed">33939658</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2023">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/neuroendocrine.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Neuroendocrine and Adrenal Tumors, 2023</CitationText>
              </Citation>
              <XRef ID="29072" DB="Orphanet" />
              <XRef ID="C0031511" DB="MedGen" />
              <XRef ID="MONDO:0008233" DB="MONDO" />
              <XRef Type="MIM" ID="171300" DB="OMIM" />
              <XRef Type="primary" ID="HP:0002666" DB="Human Phenotype Ontology" />
            </Trait>
            <Trait ID="17663" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Cowden syndrome 3</ElementValue>
                <XRef ID="MONDO:0014045" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CWS3</ElementValue>
              </Symbol>
              <XRef ID="201" DB="Orphanet" />
              <XRef ID="CN166604" DB="MedGen" />
              <XRef ID="MONDO:0014045" DB="MONDO" />
            </Trait>
            <Trait ID="3265" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Paraganglioma and gastric stromal sarcoma</ElementValue>
                <XRef ID="Paraganglioma+and+gastric+stromal+sarcoma/5577" DB="Genetic Alliance" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Carney-Stratakis syndrome</ElementValue>
                <XRef ID="MONDO:0011740" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paraganglioma and gastrointestinal stromal tumor</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Paraganglioma and GIST</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carney-Stratakis dyad of paraganglioma and gastric stromal sarcoma</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Carney dyad</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10643" />
                <XRef ID="10643" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Endocrine and Neuroendocrine Neoplasia genetics">
                <ID Source="PubMed">26389271</ID>
              </Citation>
              <Citation Type="Suggested Reading" Abbrev="NCI PDQ, Cancer Genetics Counseling">
                <ID Source="PubMed">26389258</ID>
              </Citation>
              <Citation Type="practice guideline" Abbrev="NCCN, 2024">
                <URL>https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf</URL>
                <CitationText>NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), Soft Tissue Sarcoma, 2024</CitationText>
              </Citation>
              <XRef ID="97286" DB="Orphanet" />
              <XRef ID="C1847319" DB="MedGen" />
              <XRef ID="MONDO:0011740" DB="MONDO" />
              <XRef Type="MIM" ID="606864" DB="OMIM" />
            </Trait>
            <Trait ID="8850" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Paragangliomas with sensorineural hearing loss</ElementValue>
              </Name>
              <XRef ID="C1868633" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5929628" SubmissionDate="2024-02-15" DateLastUpdated="2024-02-28" DateCreated="2023-02-07">
        <ClinVarSubmissionID localKey="17720059|MedGen:C1847319;C1868633;C0031511;C3554516" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV003240903" DateUpdated="2024-02-28" DateCreated="2023-02-07" Type="SCV" Version="2" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-12">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19454582</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19802898</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This sequence change creates a premature translational stop signal (p.Val46Hisfs*20) in the SDHD gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SDHD are known to be pathogenic (PMID: 19454582, 19802898). This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with SDHD-related conditions.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SDHD" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000011.9:g.111958663_111958670del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease" multipleConditionExplanation="Uncertain">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1847319" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1868633" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0031511" Type="CUI" />
          </Trait>
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C3554516" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12507860</SubmissionName>
          <SubmissionName>SUB14224806</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5929628" TraitType="Disease" MappingType="XRef" MappingValue="C0031511" MappingRef="MedGen">
        <MedGen CUI="C0031511" Name="Pheochromocytoma" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5929628" TraitType="Disease" MappingType="XRef" MappingValue="C1847319" MappingRef="MedGen">
        <MedGen CUI="C1847319" Name="Carney-Stratakis syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5929628" TraitType="Disease" MappingType="XRef" MappingValue="C1868633" MappingRef="MedGen">
        <MedGen CUI="C1868633" Name="Paragangliomas with sensorineural hearing loss" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5929628" TraitType="Disease" MappingType="XRef" MappingValue="C3554516" MappingRef="MedGen">
        <MedGen CUI="CN166604" Name="Cowden syndrome 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

